| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.02B | 8.71B | 8.48B | 9.51B | 10.14B | 10.34B |
| Gross Profit | -3.71B | 1.62B | 1.53B | 1.66B | 1.79B | 1.75B |
| EBITDA | 595.00M | 494.00M | 421.00M | -56.00M | 560.00M | 504.00M |
| Net Income | 132.00M | 108.00M | 165.00M | -481.00M | 71.00M | 12.00M |
Balance Sheet | ||||||
| Total Assets | 5.89B | 5.42B | 5.31B | 5.85B | 6.91B | 6.88B |
| Cash, Cash Equivalents and Short-Term Investments | 135.00M | 179.00M | 125.00M | 97.00M | 126.00M | 175.00M |
| Total Debt | 899.00M | 965.00M | 1.03B | 1.43B | 1.35B | 1.33B |
| Total Liabilities | 3.65B | 3.18B | 3.24B | 3.96B | 4.41B | 4.50B |
| Stockholders Equity | 2.24B | 2.24B | 2.07B | 1.89B | 2.50B | 2.38B |
Cash Flow | ||||||
| Free Cash Flow | 287.00M | 376.00M | 318.00M | 159.00M | 295.00M | 722.00M |
| Operating Cash Flow | 373.00M | 453.00M | 366.00M | 270.00M | 428.00M | 844.00M |
| Investing Cash Flow | -87.00M | -82.00M | 143.00M | -111.00M | -134.00M | -103.00M |
| Financing Cash Flow | -262.00M | -285.00M | -493.00M | -197.00M | -340.00M | -672.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.32B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
65 Neutral | £1.45B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
63 Neutral | £493.37M | 11.70 | 7.92% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | £352.96M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
54 Neutral | £291.34M | -0.65 | -155.17% | ― | -15.00% | 21.71% | |
47 Neutral | £575.47M | -7.96 | -90.46% | 4.48% | -30.52% | -2064.92% |